| Hauck, Susanne (Lower Saxony (govt) 202408 Investment Manager at NBank Capital) |
Investment Manager |
Niedersachsen (govt region) |
Germany |
| Hauer, Andreas (Savira Pharmaceuticals 201210– CFO before Erste Group Bank + Igeneon) |
Chief Financial Officer (CFO) |
Savira Pharmaceuticals GmbH |
Austria |
| Hauffe, Dietrich (Bruker 201508– EVP Life Sciences Mass Spectrometry at Bruker Daltonics before Qiagen + Dionex) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Haug, Markus (Volksbank Albstadt 202106 Managing Director of Volksbank Albstadt ChancenKapital GmbH) |
Managing Director |
Volksbank Albstadt eG |
Germany |
| Haug, Matthias (Bayer 201206 Head of Seed Treatment at Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Haug, Peter (Oncgnostics GmbH 201501 Business Development + Licensing Manager) |
Business Development Manager / Strategy Manager |
Oncgnostics GmbH |
Germany |
| Hauge, Elise (Lundbeck 201909– EVP People + Communication before SimCorp + Takeda + Nycomed) |
Human Resources Manager |
Lundbeck (Group) |
Denmark |
| Haugg, Norbert |
n. a. |
Deutsches Patent- und Markenamt |
Germany |
| Hauke, Sven (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech) |
Managing Director |
ZytoVision (Group) |
Germany |
| Hauner, Anna (Temedica 202308 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Temedica GmbH |
Germany |
| Haunhorst, Eberhard (Niedersachsen (govt) 201407 President of LAVES) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Haupt, Joachim (PharmAI 202204 CEO) |
Chief Executive Officer (CEO) |
PharmAI GmbH |
Germany |
| Haupt, Lena (Hessen (govt) 201411 Project Manager Life Sciences at Hessen Trade & Invest) |
Cluster Manager |
Hessen (Hesse) (govt region) |
Germany |
| Haupter, Ralph (Microsoft 202303 President of Microsoft EMEA) |
President/Director/Head Business Group/Unit/Division |
Microsoft (Group) |
United States (USA) |
| Hauptmann, Andrea (Minapharm 202004 VP Finance + Administration at ProBioGen AG) |
Financial Manager (CFO, Financial Director, etc.) |
Minapharm (Group) |
Germany |
| Haupts, Ulrich (Coral BioNet 201109– CSO of Scil Proteins GmbH before Bayer + Direvo Biotech + SKB UK) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
UV-Cap (Vetter family office) (Group) |
Germany |
| Haurum, John (F-Star 201205–201810 CEO before ImClone System + Symphogen LEFT 10/18) |
Chief Executive Officer (CEO) |
Sino Biopharm (Group) |
United Kingdom (GB) |
| Hausch, Marcus |
n. a. |
febit (Group) |
Germany |
| Hausdorf, Gabriele (Germany (govt) 201005 BMBF) |
Governmental Officer / Adminstrative Officer |
Germany (govt) |
Germany |
| Haustedt, Lars Ole (BRAIN Biotech 202202 VP Projects + Innovtion at Analyticon Discovery) |
n. a. |
BRAIN Biotech (Group) |
Germany |
| Havey, Adam (Emergent BioSolutions 201412 EVP + President Biodefense division) |
President/Director/Head Business Group/Unit/Division |
Emergent BioSolutions (Group) |
United States (USA) |
| Havlina, Roxana (Rovalab 201104 Managing Director) |
Managing Director |
Rovalab GmbH |
Germany |
| Hawa, Gerhard Hawa (Fianostics GmbH 201510 CEO) |
Chief Executive Officer (CEO) |
Fianostics GmbH |
Austria |
| Hawkins, Rick (Lumos Pharma 201604 CEO) |
Chief Executive Officer (CEO) |
Lumos Pharma (US) |
United States (USA) |
| Hawkins, Tim (Schauenburg 201308– Finance Director at Markes Intl before PriceWaterhouseCoopers) |
Chief Financial Officer (CFO) |
Schauenburg (Group) |
United Kingdom (GB) |
| Hawkins, Trevor (ProGenTech 200810 Chairman + CEO) |
Chief Executive Officer (CEO) |
ProGenTech (Group) |
United States (USA) |
| Hayday, Adrian (Professor + Co-Founder of ImmunoQure) |
n. a. |
ImmunoQure (Group) |
Germany |
| Hayden, Michael R. (Forbion 202203– Venture Partner + Prilenia Therapeutics 202006– CEO former CSO at Teva) |
Venture Partner |
Forbion (Group) |
Netherlands |
| Hays, Anne (Lonza 201412 Head Custom Development Services Organisation) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Switzerland |
| Hayward, Colin (Myriad 201501 European Medical Director) |
n. a. |
Myriad Genetics (Group) |
United States (USA) |
| Hazenberg, Wil (BioGeneration Ventures 201112 Partner) |
Partner (venture partner) |
BioGeneration Ventures B.V. (BGV) |
Netherlands |
| Hazlewood, Matt (Thermo Fisher 202003 Senior Director Global Chromatography Data Systems) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| He, Sylvia Xin (Hyfinity Investments 201912 Managing Partner) |
Managing Partner |
Hyfinity Investments (CN) |
China |
| He, Yingke (Synthetica Pioneering 202407 CEO) |
Chief Executive Officer (CEO) |
Synthetica Pioneering (CN) (Group) |
China |
| Headly, Martin S. (Brooks Automation –201309 CFO LEFT 9/13) |
Chief Financial Officer (CFO) |
Azenta (Group) |
United States (USA) |
| Healey, Joseph R.J. (Joe) (NanoSyrinx 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NanoSyrinx Ltd. |
United Kingdom (GB) |
| Healy, James I. (Jim) (Sofinnova Ventures 200701 General Partner) |
General Partner (venture partner) |
Sofinnova (Group) |
United States (USA) |
| Heard, Edith (EMBL 202107 Director General) |
President/Director/Head of Research Organisation/Unit |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Hecht, Frank (CellGenix 201702 VP Marketing + Sales) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
| Hecht, Peter (Oridis Biomed 200502– CEO before Tripos) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Austria |
| Hecht, Robert (Olympus 200812 Managing Director Olympus Diagnostics Europe) |
Managing Director |
Olympus (Group) |
Germany |
| Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman) |
Board member, non-executive |
Athenex (Group) |
Switzerland |
| Heck, Albert J. R. (Univ Utrecht 199809– Prof + Head Biomolecular Mass Spec & Proteomics Group) |
Professor |
University of Utrecht (Utrecht University) |
Netherlands |
| Hecker, Michael (Univ Greifswald 201312 Professor) |
Professor |
University of Greifswald |
Germany |
| Heckl, Wolfang M. (LMU München 200505) |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Heckle, Sven (Börse Inside 200511) |
n. a. |
Börse Inside AG |
Germany |
| Hedegaard, Anders (Bavarian Nordic 200708– CEO) |
Chief Executive Officer (CEO) |
Bavarian Nordic (Group) |
Denmark |
| Hediard, Florent (SGS 201610 Life Sciences Marketing Director Agriculture + Food + Life) |
Sales Manager / Marketing Manager |
SGS (Group) |
Switzerland |
| Hédou, Gaël (Relief Therapeutics 201610 COO) |
Chief Operating Officer (COO) |
Relief Therapeutics (Group) |
Switzerland |
| Heeger, Steffen (Full-Life Technologes 202407 CMO formerly Selvita + MorphoSys + Merck Serono) |
Chief Medical Officer (CMO) |
Full-Life Technologies (Group) |
Germany |
| Heeren, Ron M. A. (Maastricht Univ 2015 Co-Director of M4I Institute before FOM Amsterdam 200808) |
Professor |
Maastricht University (Universiteit Maastricht, UM) |
Netherlands |
| Heffernan, Michael (Mike) (Avenge Bio 202201 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Avenge Bio Inc. |
United States (USA) |
| Hegendörfer, Thomas (Max Planck 201104 Head Business Development of Lead Discovery Center GmbH) |
Business Development Manager / Strategy Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Heggie, Theresa (Freeline Therapeutics 202006– CEO before Alnylam + Shire + Jerini + Baxter + Janssen) |
Chief Executive Officer (CEO) |
Freeline Therapeutics (Group) |
United Kingdom (GB) |
| Hehman, Hilary (Fred Hutchinson 201805 Director of Partnerships + Alliances) |
Business Development Manager / Strategy Manager |
Fred Hutchinson Cancer Research Center (Seattle, WA) |
United States (USA) |
| Heibel, Hauke (microDimensions GmbH 2011– Managing Director (CTO) + Co-founder) |
Managing Director |
microDimensions GmbH |
Germany |
| Heiberger, Kurt (Eyesight & Vision 201006– Managing Director + Co-founder) |
Managing Director |
Eyesight & Vision GmbH |
Germany |
| Heid, Conrad (Lymphera 202309– Co-Founder) |
company founding |
Symphera GmbH |
Germany |
| Heidecker, Martin (AMR Action Fund 202301 Chief Investment Officer before Boehringer Ingelheim Venture Fund) |
Investment Manager |
AMR Action Fund |
|
| Heiden, Stefanie (DBU + Univ Osnabrück 200501) |
n. a. |
Deutsche Bundesstiftung Umwelt DBU |
Germany |
| Heidinger, Ann (Calibre Scientific 202303 CFO) |
Chief Financial Officer (CFO) |
Calibre Scientific (Group) |
United States (USA) |
| Heidtke, Karsten (Atlas Biolabs 201009 Head Bioinformatics) |
n. a. |
Atlas Biolabs GmbH |
Germany |
| Heikenwälder, Mathias (Helmholtz 201904 Prof + Group Leader at DKFZ) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Heiker, Fred-Robert (Bayer) |
n. a. |
Bayer (Group) |
Germany |
| Heim, Jutta (Evolva –201304 CSO STEPPED DOWN 4/13 before CTO before Basilea CSO + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Lallemand (Group) |
Switzerland |
| Heimbrook, David (Roche 200310) |
n. a. |
Roche (Group) |
Switzerland |
| Heimer, Jon (Olink 201510 CEO) |
Chief Executive Officer (CEO) |
Navinci Diagnostics AB |
Sweden |
| Hein, Frauke (Bico 202206– CEO of Scienion before MLDx GmbH + Adrenomed + BRAHMS + Brandenburg) |
Chief Executive Officer (CEO) |
Bico (Group) |
Germany |
| Hein, Mich (Electrochaea 202201 CEO) |
Chief Executive Officer (CEO) |
Electrochaea GmbH |
Germany |
| Hein, Sören (MIG Fonds 202011 Partner) |
Partner (venture partner) |
MIG Fonds (Group) |
Germany |
| Heindl, Walter (Delta 4 202106 Advisory Council Member) |
Advisory Board member |
Delta 4 GmbH (Delta4) |
Austria |
| Heine, Birgit (Sachsen Anhalt (govt) 201301 Senior Manager Life Sciences at IMG) |
Cluster Manager |
Saxony-Anhalt (govt region) |
Germany |
| Heine, Oliver (MESI 2022– Investor + Advisor) |
Investment Manager |
SHS Capital (Group) |
Germany |
| Heiniö, Jussi (Sartorius 201112– before Biohit CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Germany |
| Heinold, Bernd (Deutsche Messe 201502 Director Intl Trade Fairs + Exhibitions) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
| Heinrich, Günther (Epidauros Founder) |
Company Founder |
Danaher (Group) |
Germany |
| Heinrich, Peter (Alira Health 202005 Partner + Sinfonie LS 201206– Managing Director before MagForce + MediGene) |
Managing Director |
Alira Health (CMC Consulting Boston) (Group) |
Germany |
| Heinrichs, Diana (Lindera 20211 Managing Director + Founder) |
Managing Director |
Lindera GmbH |
Germany |
| Heinrichs, Hubert (Antisense Pharma 201012 Managing Director) |
Managing Director |
Isarna Therapeutics GmbH |
Germany |
| Heinricht, Frank (Schott 202108 CEO) |
Chief Executive Officer (CEO) |
Schott (Group) |
Germany |
| Heintze, Déborah (Lunaphore Technologies 201404– COO + Co-Founder) |
Chief Operating Officer (COO) |
Bio-Techne (Group) |
Switzerland |
| Heinz, Dirk (Helmholtz 201108–202306 Scientific Director of HZI Braunschweig since 1998 at GBF/HZI) |
President/Director/Head Business Group/Unit/Division |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Heinz, Louis (High-Tech Gründerfonds 202302 Senior Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Heinze-Krauss, Ingrid (Basilea 2000–201601 joined at founding 2000 + will retire 201601) |
Chief Technology/Technical Officer (CTO) |
Basilea (Group) |
Switzerland |
| Heinzel, Matthias (Merck (DE) 202201 Executive Board Member + CEO Life Science) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Heinzen, Christoph (Alicon AG 200810 CEO) |
Chief Executive Officer (CEO) |
Alicon AG |
Switzerland |
| Heise, Jörg (Somatex Medical Technologies 202101 Managing Director) |
Managing Director |
Hologic (Group) |
Germany |
| Heise, Tim (Profil GmbH 201403 Managing Director) |
Managing Director |
Profil Institut für Stoffwechselforschung GmbH |
Germany |
| Heiser, Lia (Carl Roth 202411) |
n. a. |
Carl Roth GmbH + Co. KG |
Germany |
| Heister, Peter |
n. a. |
PERSON |
Germany |
| Helbig, Ingo (Univ Kiel 201203 Professor Dept of Neuropediatrics UKSH Kiel) |
Professor |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Helbling, Paul (Dualsystems Biotech 201309 Business Development Sales and Marketing) |
Business Development Manager / Strategy Manager |
Dualsystems Biotech (Group) |
Switzerland |
| Heldt, Markus (BASF 201310 President of Crop Protection division) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
| Helfenstein, Roland (Numab 2011– CFO) |
Chief Financial Officer (CFO) |
Numab (Group) |
Switzerland |
| Helftenbein, Elke (Antigene Biotech GmbH –201201 Managing Director) |
Managing Director |
Antigene Biotech GmbH |
Germany |
| Hélin, Guy (Syngulon 201809 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Syngulon S.A. |
Belgium |
| Hell, Stefan W. (Max Planck 201503 Director at MPI for biophysical Chemstry in Göttingen) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Helle, Norbert (TeLa GmbH 200902 Managing Director) |
Managing Director |
Sirius Fine Chemicals SiChem GmbH |
Germany |
| Heller, Barbara (Santhera 200701 CFO) |
Chief Financial Officer (CFO) |
Santhera (Group) |
Switzerland |
| Heller, Damian (Basilea 201708– General Counsel + Corp Secretary joined 2015 before Novartis Pharma + Syngenta) |
General Counsel / Chief Legal Officer (CLO) |
Basilea (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 31 32 33 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
